1029 WITHDRAWAL VERSUS CONTINUATION OF THIOPURINE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS (VIEWS): A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL
Aviv Pudipeddi(The University of Sydney), Rupert W. Leong(The University of Sydney), Craig Haifer(University of Sydney), Ramesh Paramsothy(Liverpool Hospital), Peter De Cruz(The University of Melbourne), Mark Ward, Simon Ghaly(UNSW Sydney), Susan J. Connor(Liverpool Hospital), Pak Wo Chan, Viraj C. Kariyawasam(Concord Repatriation General Hospital), Diane Redmond(Concord Repatriation General Hospital), Jakob Begun(Translational Research Institute), Yoon‐Kyo An(Mater Hospital), Crispin Corte(Royal Prince Alfred Hospital), Sudarshan Paramsothy(University of Chicago), Caroline Fung, Fadi H. Mourad(Concord Repatriation General Hospital)
Cited by 2
Related Papers
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
|Journal of Crohn s and Colitis|2017|425
Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis
|PLoS Genetics|2013|217
Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study
|Journal of Crohn s and Colitis|2013|114
Defined microbiota transplant restores Th17/RORγt <sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas
|Proceedings of the National Academy of Sciences|2020|107
Ulcerative Colitis and Cytomegalovirus Infection: From A to Z
|Journal of Crohn s and Colitis|2020|102